Guru Ownership Trend
Guru Analysis for Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $424.74 M.
Top institutional holders include Renaissance Technologies (RenTech) and Manning & Napier Group.
Institutional sentiment is currently Bearish. This is evidenced by a $138.64 M net outflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 23.6%. Conversely, Ray Dalio reduced exposure by 51.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Vertex Pharmaceuticals Incorporated (VRTX)
Major holders include Renaissance Technologies (RenTech) ($188.3 M), Manning & Napier Group ($98.5 M), Cliff Asness ($76.03 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 942,907 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $138.64 M, with 3 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 5 managers trimmed their positions, while 2 fully exited VRTX. The total reported sell value was $154.02 M.
Yes, 0 managers opened new positions in VRTX, and 3 increased their existing holdings. The total reported buy value was $15.38 M.
